← Leaderboards
Meihong Deng
Feinstein Institute For Medical Research
$2,514,366
Attributed
$2,514,366
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $460.6K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,514,366 · 2
By mechanism
R01$2,053,741 · 1
R21$460,625 · 1
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Betty Diamond$68,537,262
- Ping Wang$26,716,102
- Sangeeta S. Chavan$4,793,336
- Valentin Atanassov Pavlov$3,158,802
- Monowar Aziz$2,651,696
Others in their field
Other Emerging Leaders on “Organ”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
OrganGene ExpressionImmunoregulationSepsisCessation Of LifeFlow CytometryGenesImmune ResponseRegulationSingle-Cell Rna SequencingMortalityImmuneCellsCell PhysiologyBiological Response ModifiersAdipose TissueEscherichia ColiExperimental ModelsExtracellular MatrixCecal Ligation PunctureClinical TranslationCytometryCell CommunicationAbdominal Infection
Grant awards (8)
Role of post-sepsis exercise therapy in regulating CD4 T cell immunity against secondary Pseudomonas aeruginosa infection$460,625
R21 · FY2025 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$425,886
R01 · FY2024 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$434,478
R01 · FY2023 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$210,237
R01 · FY2022 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$193,270
R01 · FY2022 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$376,771
R01 · FY2021 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$259,704
R01 · FY2020 · AI · contact PI
Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis$153,395
R01 · FY2020 · AI · contact PI